Botulinum toxin for hereditary spastic paraplegia: effects on motor and non-motor manifestations
ABSTRACT Motor and non-motor manifestations are common and disabling features of hereditary spastic paraplegia (HSP). Botulinum toxin type A (Btx-A) is considered effective for spasticity and may improve gait in these patients. Little is known about the effects of Btx-A on non-motor symptoms in HSP...
Saved in:
| Main Authors: | Katiane R. Servelhere, Ingrid Faber, Alberto Martinez, Renato Nickel, Adriana Moro, Francisco M. B. Germiniani, Mariana Moscovich, Tatiane R. Blume, Renato P. Munhoz, Hélio A. G. Teive, Marcondes C. França Jr |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000300183&lng=en&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical features and management of hereditary spastic paraplegia
by: Ingrid Faber, et al.
Published: (2014-03-01) -
Translation and validation into Brazilian Portuguese of the Spastic Paraplegia Rating Scale (SPRS)
by: Katiane R. Servelhere, et al.
Published: (2016-06-01) -
Tratamento da espasticidade: uma atualização
by: HÉLIO A.G. TEIVE, et al.
Published: (1998-12-01) -
Effects of botulinum toxin type A for spastic foot in post-stroke patients enrolled in a rehabilitation program
by: Leonardo Halley Carvalho Pimentel, et al.
Published: (2014-01-01) -
Hereditary spastic paraplegia from 1880 to 2017: an historical review
by: Ingrid Faber, et al.